Upregulation of thioredoxin-1 in activated human NK cells confers increased tolerance to oxidative stress.

about

Redox control of cancer cell destruction.In Vitro Modulation of Redox and Metabolism Interplay at the Brain Vascular Endothelium: Genomic and Proteomic Profiles of Sulforaphane Activity

P2860

Q51748168-0EACCDED-B5A3-492B-BDE6-6643D20B91C5 Q58714736-E5DA200F-88A7-4E08-A694-61570991BA5B

P2860

Upregulation of thioredoxin-1 in activated human NK cells confers increased tolerance to oxidative stress.

Item

http://www.wikidata.org/entity/Q38715422

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Upregulation of thioredoxin-1 ...... tolerance to oxidative stress.

@en

type

Item

label

Upregulation of thioredoxin-1 ...... tolerance to oxidative stress.

@en

prefLabel

Upregulation of thioredoxin-1 ...... tolerance to oxidative stress.

@en

P1476

Upregulation of thioredoxin-1 ...... tolerance to oxidative stress

@en

P2093

Kensuke Shiraishi

http://www.w3.org/2001/XMLSchema#string

Koji Kono

http://www.w3.org/2001/XMLSchema#string

Kousaku Mimura

http://www.w3.org/2001/XMLSchema#string

Ley-Fang Kua

http://www.w3.org/2001/XMLSchema#string

Lim Kee Siang

http://www.w3.org/2001/XMLSchema#string

Noriko Shimasaki

http://www.w3.org/2001/XMLSchema#string

Shotaro Nakajima

http://www.w3.org/2001/XMLSchema#string

Wei-Peng Yong

http://www.w3.org/2001/XMLSchema#string

P2860

Regulatory role for a novel human thioredoxin peroxidase in NF-kappaB activation

Interleukin-2 receptor signaling: at the interface between tolerance and immunity

Nivolumab in previously untreated melanoma without BRAF mutation

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer

Controlled elimination of intracellular H(2)O(2): regulation of peroxiredoxin, catalase, and glutathione peroxidase via post-translational modification.

NK cell-based immunotherapy for malignant diseases.

Interleukin-2 and interleukin-15: immunotherapy for cancer.

Inhibition of mitogen-activated protein kinase pathway can induce upregulation of human leukocyte antigen class I without PD-L1-upregulation in contrast to interferon-γ treatment.

Interleukin-2, interleukin-15, and their roles in human natural killer cells.

The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design.

P2888

s00262-017-1969-z

P304

605-613

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00262-017-1969-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Asim Shabbir

Jimmy So

P577

2017-02-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1083855075

http://www.w3.org/2001/XMLSchema#string

P698

28224212

http://www.w3.org/2001/XMLSchema#string

Upregulation of thioredoxin-1 in activated human NK cells confers increased tolerance to oxidative stress.

about

P2860

P2860

Upregulation of thioredoxin-1 in activated human NK cells confers increased tolerance to oxidative stress.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698